ctrl K

Sino Biopharmaceutical Li... (SBHMY)

PNK: SBHMY · Real-Time Price · USD

9.48

0.00 (0.00%)

At close: Apr 21, 2025, 3:37 PM

Sino Biopharmaceutical Income Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	26.2B	26.03B	26.86B	23.65B	24.23B	20.89B	14.82B	13.54B
Cost of Revenue	4.99B	4.49B	5.33B	5.18B	4.93B	4.2B	3.09B	2.82B
Gross Profit	21.21B	21.54B	21.53B	18.46B	19.31B	16.69B	11.73B	10.73B
Operating Income	5.79B	5.48B	4.35B	4.3B	5.2B	4.32B	3.26B	4.71B
Interest Income	186.68M	195.91M	162.06M	194M	257.71M	162.72M	83.06M	38.88M
Pretax Income	5.41B	5.21B	18.57B	5.01B	5.69B	11.43B	4.2B	3.2B
Net Income	2.33B	2.54B	14.61B	2.77B	2.76B	9.05B	2.17B	1.64B
Selling & General & Admin	11.07B	11.71B	12.7B	11.63B	11.8B	10.27B	6.9B	6.49B
Research & Development	4.4B	4.24B	n/a	2.63B	2.4B	2.09B	1.6B	1.37B
Other Expenses	-45.79M	106.02M	4.47B	-94.52M	n/a	13.56M	n/a	-1.85B
Operating Expenses	15.42B	16.06B	17.18B	14.16B	14.22B	12.37B	8.47B	6.01B
Interest Expense	495.24M	429.49M	308.62M	323.37M	229.95M	153.26M	77.94M	76.65M
Selling & Marketing Expenses	9.19B	9.81B	10.52B	8.97B	9.32B	8.08B	5.92B	5.45B
Cost & Expenses	20.41B	20.55B	22.51B	19.34B	19.16B	16.57B	11.59B	8.83B
Income Tax Expense	797.27M	696.72M	1.96B	672.38M	902.75M	696.24M	542.29M	474.98M
Shares Outstanding (Basic)	1.17B	931.11M	938.43M	47M	940.58M	927.43M	833.87M	833.87M
Shares Outstanding (Diluted)	926.45M	950.86M	964.15M	47M	940.55M	927.43M	833.87M	833.87M
EPS (Basic)	1.58	5.40	15.60	4.60	5.00	9.80	2.60	1.96
EPS (Diluted)	1.99	5.20	14.60	4.60	5.00	9.80	2.60	1.96
EBITDA	6.98B	6.69B	19.87B	6.99B	7.37B	12.76B	4.62B	3.6B
EBIT	5.91B	5.64B	18.88B	5.34B	5.92B	11.58B	4.27B	3.28B
Depreciation & Amortization	1.07B	1.05B	992.56M	1.65B	1.47B	1.18B	343.39M	317.4M